Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

12.78
Delayed Data
As of Mar 26
 -0.48 / -3.62%
Today’s Change
10.85
Today|||52-Week Range
18.48
-9.68%
Year-to-Date

Today’s Trading

Previous close13.26
Today’s open13.13
Day’s range12.65 - 13.25
Volume2,696,938
Average volume (3 months)1,724,025
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 03/26/2015

Growth & Valuation

Earnings growth (last year)-112.07%
Earnings growth (this year)+25.54%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+54.64%
P/E ratioNM
Price/Sales118.95
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NKTRNektar Therapeutics-0.11-1.00%
ARIAARIAD Pharmaceutical...+0.08+0.99%
NXTMNxStage Medical Inc-0.16-0.94%
SGMOSangamo BioSciences ...-0.12-0.80%
Data as of 3:59pm ET, 03/26/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$10.8M
Annual profit (last year)-$111.5M
Net profit margin-1,030.19%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ronald Bentsur
President, Chief Operating Officer &
Director
Gregory P. Madison
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account